NCT03106974

A Comparison of Tracheal Intubation Using the Totaltrack vs the Macintosh Laryngoscope in Obese Patients

A Comparison of Tracheal Intubation Using the Totaltrack vs the Macintosh Laryngoscope

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 1,440 (estimated)
• Sponsor: AnestesiaR · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Airway management in obese patients has to consider that mask ventilation (DMV) risk is increased and difficult tracheal intubation (DTI) risk may be increased too. In obese patients, is essential to prevent early arterial oxygen desaturation related to a reduced functional residual capacity (FRC), atelectasis formation during anesthetic induction and after tracheal intubation, because oxygenation maintenance is the cornerstone of the airway management of the obese patient. Endotracheal intubation is usually required to allow unrestricted surgical approach. The Macintosh laryngoscope is the standard method. However, sometimes this technique is ineffective and poorly tolerated by the obese patient. The Totaltrack™ (MedComflow S.A., Barcelona, Spain) is a hybrid device, between a supraglottic airway and a videolaryngoscope with an anatomically shaped blade. It allows fibreoptic visualization of the larynx for tracheal intubation and was developed to aid both ventilation and tracheal intubation, at the time of anticipated and unanticipated difficult airway management. However, despite its use in clinical practice, there are no comparative studies regarding direct laryngoscopy in obese patients.

Conditions

• Endotracheal Intubation
• Obesity
• Desaturation
• Ventilation

Interventions

Type	Name	Description
DEVICE	orotracheal intubation Macintosh Laryngoscope	orotracheal intubation (OTI) after induction of anesthesia and complete relaxation
DEVICE	orotracheal intubation Totaltrack VLM	orotracheal intubation (OTI) after induction of anesthesia and complete relaxation

Timeline

• Start date: 2017-05-01
• Primary completion: 2018-05-01
• Completion: 2019-05-01
• First posted: 2017-04-11
• Last updated: 2017-04-14

Locations

1 site across 1 country: Spain

Regulatory

• FDA-regulated device study